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Lead is a ubiquitous environmental contaminant; nearly 5%
of American children are affected by lead poisoning (a blood
lead level (BLL) of 10 mg dL1 or higher).[1] Even lower BLLs
have been shown to cause many subtle health effects in
children. Lead, which is found in paint and soil, causes toxicity
by several possible mechanisms. Pb2+ interacts with several
zinc enzymes or proteins (such as carbonic anhydrase,
acetylcholine esterase, Cys2His2 “zinc-finger” proteins, and
acid phophatases) [2,3] and calcium ion binding proteins
(calmodulin, calbindin, and troponin C).[4] Inhibition of
protein function is induced by alternative coordination
number and structural preferences.[5, 6] Pb2+ is a chemically
interesting toxin in that it can replace calcium and sometimes
zinc in “hard” active sites that are oxygen/nitrogen rich; it can
also attack softer ligands, such as all-sulfur-containing zinc ion
coordination sites. Among the sulfur-rich targets for Pb2+ are
glutathione and metallothioneines, which cause perturbations
of essential metal ion homeostasis.
Aminolevulinic acid dehydratase (ALAD), a zinc-depen-
dent enzyme, is inhibited by a femtomolar concentrations of
Pb2+.[2] ALAD is found in yeast and mammals and is involved
in the second step of heme biosynthesis. Pb2+-poisoned
ALAD blocks the synthesis of hemoglobin, causing anemia
in mammals. Furthermore, toxic levels of aminolevulinic acid
can result. The crystal structure of ALAD contains an unusual
Zn(Cys)3H2O site, where Zn
2+ is substituted by Pb2+ in a
trigonal pyramidal geometry.[7] The high affinity of Pb2+ to
cysteine thiolates is presumably due to the high enthalpy of
PbS bond formation and the preferred PbS3 coordination
geometry in thiolate-rich sites of proteins.[8] A number of
peptides[9–11] and small-molecule synthetic models[12] have
been used to understand the chemistry of the PbII-poisoned
ALAD. UV/Vis and EXAFS studies on the metalloregulatory
protein Pb-PbrR691 and Pb2+ model compounds reveal that
Pb2+ binds in a PbS3 environment.
[13]
Heteronuclear magnetic resonance spectroscopy with
nuclei such as 43Ca, 113Cd, and 199Hg has been a powerful
tool for studying the active site structures of metalloenzymes
and their model compounds.[14–21] Similarly, lead provides an
NMR active nucleus (207Pb, nuclear spin I = 1/2) with a natural
abundance of 22.6% and a relatively good receptivity (11.7
times higher than that of 13C).[22] However, owing to the wide
chemical shift range (over 16000 ppm), the use of 207Pb NMR
spectroscopy is non-trivial.[8,22–24]
Recently, Vogel and co-workers utilized 207Pb NMR
spectroscopy (using isotopically enriched 207Pb) to study
Pb2+ binding to the Ca2+ site of calcium-binding proteins,
including calmodulin (CaM).[25] To our knowledge, this is the
sole example of 207Pb NMR as a probe in metalloproteins. Of
great importance, there are no reported 207Pb spectra for
sulfur-rich metalloproteins. A number of small synthetic
molecules with or without mixed O, S, and N donor ligands
(for example S2O2, S2N2, N2O4, N3O3, N4, N6) have been
characterized using this technique.[22–24, 26–28] The 207Pb NMR
signal for the thiol-rich binding sites should be shifted further
downfield than that of oxygen- and nitrogen-rich calcium-
binding sites. Thus, we can distinguish PbS3 versus PbS3O
coordination environments very easily by using 207Pb NMR.[22]
The coordination number and geometry of the Pb2+ ion can
also be examined.[29] Dean, Payne, Christou, and their co-
workers have synthesized [Ph4As][Pb(SPh)3] and character-
ized complexes in non-aqueous media using 207Pb NMR
spectroscopy.[30–32] Despite these studies, no significant
advancement of 207Pb NMR has been accomplished to
explore the thiolate-rich proteins scaffolds. Herein, we
present the 207Pb NMR for a physiologically relevant coordi-
nation environment of thiolate-rich metallopeptides in the
preferred homoleptic trigonal pyramidal geometry for PbII
ions by utilizing three-strand coiled-coil peptides. To our
knowledge, this is the first report of 207Pb NMR spectroscopy
used in a Cys3 motif that can be a direct probe for the thiol-
rich metalloenzymes, such as ALAD, which are directly
implicated in human lead poisoning.
We have utilized new three-strand coiled-coil (3-SCC)
peptides (CoilSer and TRI family) to obtain insight into how
toxic metals, such as Hg2+, As3+, Cd2+, and Pb2+, bind in thiol-
rich sites of metalloenzymes.[19–21, 33–38] These a-helical peptide
families have heptad repeats of seven amino acid residues that
contain hydrophobic leucine residues in the a (first) and d
(fourth) positions (Table 1).[39] The resultant 3-SCC has all of
the hydrophobic leucine residues packed on the interior of the
3-SCC and hydrophilic residues (e and g) on the exterior,
forming salt bridges that stabilize the coiled coil. A metal
binding site can be created by the substitution of a leucine by
cysteine in the a or d positions of the heptad repeat unit to
give a metal binding site within the hydrophobic core of the
peptide trimer.[35, 39] The sulfur atoms in an a site are oriented
towards the interior of the coiled coil and preorganized for
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metal binding, whereas the sulfur atoms in a d site point away
from the interior towards the helical interface, creating a
relatively larger cavity (Figure 1). Metal ions such as Cd2+,
Hg2+, and As3+ are preferentially bound to the a site, whereas
larger metal ions such as Pb2+ prefer the d site.[40]
The use of these well-defined peptides provides several
advantages for detecting the 207Pb signal in an all-thiolate
(homoleptic) environment that mimics ALAD. In contrast to
small organic lead thiolate complexes, the designed peptides
are highly soluble and stable in water. Therefore, 207Pb NMR
studies at relatively high concentrations (10–12 mm) and
physiological pH is successful without peptide aggregation or
Pb(OH)2 precipitation. Similar preparations were unsuccess-
ful for cysteine, which was due to the precipitation of a PbCys3
complex that can only be dissolved at high pH (> 12). Thus, a
solely PbS3 coordination environment cannot be attained by
cysteine at physiological pH.
Binding studies of Pb2+ to TRIL12C and TRIL16C were
previously monitored by UV/Vis, EXAFS, and CD spectros-
copy[35] and shown to have high affinity (> 108m1) with the
peptides studied herein. The presence of a characteristic
ligand-to-metal charge-transfer (LMCT) band at about
345 nm (e 3500Lmol1 cm1) is indicative of PbS3 in a
trigonal pyramidal geometry. Recent EXAFS studies by
Matzapetakis et al. identified a three-coordinate Pb2+ site in
Pb(TRIL16C)3
 with PbS scatters at 2.63 . Similar results
have been reported by Giedroc and co-workers for the
preference of Pb2+ for a PbS3 coordination environment in the
metalloregulatory protein CadC.[41,42] This data compares well
with PbS scatters found for the lead-inhibited active site of
ALAD. Therefore, the metallopeptides described herein are
in close approximation to the Pb2+-
inhibited active site of ALAD and
related lead-binding proteins.
The natural-abundance 207Pb
NMR spectra of all of the metal-
lopeptides with a single binding site
had a single lead signal at 5500–
5800 ppm with broad linewidths
(15–25 pm) (Figure 2). Similar
broad signals have been reported in protein NMR studies
with 199Hg and 205Tl, which may be due to nuclear relaxation
by chemical shift anisotropy (CSA).[43, 44] The peptides with a d
metal binding site have downfield chemical shifts relative to
those of the a site peptides. Several interesting trends can be
extracted from these data: similar chemical shifts for the
peptides having a d site are seen independent of the length of
the peptide or the intrinsic stability of the aggregate, Pb-
(BabyL12C)3
 (d = 5786 ppm, w1/2 = 20 ppm) and Pb-
(CSL12C)3
 (d = 5814 ppm, w1/2 = 18 ppm). These chemical
shifts are similar to the previously reported trigonal pyrami-
dal PbS3 structure of a small synthetic organic compound
[Ph4As][Pb(SPh)3] (d = 5828 ppm).
[31] The possibility of for-
mation of nitrogen- or oxygen-bound species can be ruled out
as a distinct upfield chemical shift has been observed for
mixed-donor ligand types (PbN2S, d = 5318 ppm; PbS2O2, d =
4100–4500 ppm).[8, 24, 26] Therefore, the observed 207Pb signal
can be confidently assigned to the formation of a PbS3
coordination environment.
An upfield chemical shift of approximately 200 ppm was
observed when a lead-binding site was created in the a site
peptide (Pb(CSL16C)3
 ; d = 5612 ppm, w1/2 = 18 ppm). Fur-
Table 1: Sequence and name of the peptides used in this study.
Peptides
Sequence
Ac-E abcdefg abcdefg abcdefg abcdefg
CSL12C Ac-E WEALEKK LAACESK LQALEKK LEALEHG-NH2
CSL16C Ac-E WEALEKK LAALESK CQALEKK LEALEHG-NH2
CSL12AL16C Ac-E WEALEKK LAAAESK CQALEKK LEALEHG-NH2
BabyL12C Ac-G LKALEEK LKACEEK LKALEEK G-NH2
GrandL12AL16CL26C Ac-G LKALEEK LKAAEEK CKALEEK LKACEEK LKALEEK G-NH2
Figure 1. Pymol representation showing the orientation of cysteine
residues. a) CoilSerL12C, d site; b) CoilSerL16C, a site. Cysteine side
chains are shown as sticks and peptide a helices are shown as coils.
PDB code: 3H5F.[45] Figure 2. Natural-abundance
207Pb NMR spectra (104.435 MHz) of
PbII-bound three-strand coiled-coil peptides (10–12 mm): a) Pb-
(BabyL12C)3
 , b) Pb(CSL12C)3
 , c) Pb(CSL16C)3
 ,
d) Pb(CSL12AL16C)3
 , e) Pb2(GrandL12AL16L26C)3
2, f) Pb(Grand-
L12AL16L26C)3
 . All spectra were recorded for 10–12 h using natural-
abundance Pb(NO3)2, (
207Pb= 22.6%), pH 7.350.05, at 25 8C.
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thermore, substitution of a sterically less-demanding amino
acid residue above the a metal binding site leads to a
55–60 ppm further upfield shift (Pb(CSL12AL16C)3
 ; d =
5555 ppm, w1/2 = 25 ppm). We conclude that
207Pb NMR
spectroscopy is sufficiently sensitive to distinguish between
two similar trigonal pyramidal PbS3 centers based on the a
versus d substitution pattern of the peptide. Furthermore, the
upfield shift in the Pb(CSL12AL16C)3
 suggests that the
additional space provided above the PbS3 plane by the alanine
accommodates the bulky Pb2+ lone pair within the helical
assembly better. A similar rationale can be applied to the
longer Pb2(GrandL12AL16L26C)3
2, in which the leucine
layer above the a site is substituted by alanine and leucines at
the 16th (a) and 26th (d) sites are replaced with cysteines,
creating two Pb2+ binding sites. The d site has a 207Pb NMR
signal at d = 5796 ppm (Figure 2 e; w1/2 = 17 ppm); this value
is between the signal obtained for Pb(BabyL12C)3
 and
Pb(CSL12C)3
 , but clearly in the region of d cysteine ligands.
A 207Pb peak at 5538 ppm (w1/2 = 18 ppm) is assigned to the a
site with a hole oriented towards the N terminus, which
compares well with the value obtained for
Pb(CSL12AL16C)3
 . These data illustrate that 207Pb NMR
is sufficiently sensitive to discriminate complexation of Pb2+
in these similar yet non-identical sites. Furthermore, the
simultaneous observation of both peaks and the relatively
narrow linewidths suggest that the Pb2+ ions are in slow
exchange on the NMR timescale.
Interestingly, the addition of one equivalent of Pb(NO3)2
into GrandL12AL16L26C gives a 207Pb signal at the a site
region only (d = 5546 ppm, w1/2 = 19 ppm), indicating a selec-
tive binding of Pb2+ to the a site with a hole above (Figure 2 f).
This observation is in contrast to the previously reported a
versus d preference for Pb2+ complexation. The inversion of
selectivity is a consequence of the added space made available
by substituting alanine for leucine. The steriochemically
active lone pair of Pb2+ no longer clashes with the alkyl side
chain of leucine and can now be accommodated within the
generated cavity, leading to a higher thermodynamic stability
of lead binding. It has been shown that Cd2+, which forms a
mixture of three- (CdS3) and four-coordinate (CdS3(H2O))
structures with TRIL16C, becomes fully four-coordinate,
using an exogenous water ligand, when space is made
available above the metal by the same leucine to alanine
substitution in TRIL12AL16C.[46]
These results provide experimental confirmation of the
importance of the lone pair on the selectivity of Pb2+ for sulfur
sites in proteins such as PbrR691 and ALAD (in which Pb2+
displaces Zn2+ from three cysteines and one exogeneous
water rather than the five-coordinate zinc binding site with
nitrogen and oxygen atoms as ligands). These data suggest
that there will be a significant preference for Pb2+ to be
sequestered into an environment that provides sufficient
space to accommodate the large lone pair of this ion. Such a
situation exists when Pb2+ displaces Zn2+ in ALAD.
Despite the fact that lead-substituted ALAD is strongly
implicated in lead toxicity, to date there have been no
examples of biomolecules or model compounds that have
exhibited a 207Pb NMR spectrum for a PbS3 center in aqueous
solution at physiological pH. Our ability to detect such a
chromophore using natural-abundance isotope levels, to
illustrate the sensitivity of the chemical shift range and to
demonstrate how slight amino acid sequence changes affect
lead binding to a protein are significant advances for under-
standing the biochemistry of human lead poisoning. Our data
also indicate that Pb2+ exchange between homoleptic thiolate
sites is slow on the NMR timescale. Most importantly, we
have demonstrated that high-quality spectra do not require
expensive enriched 207Pb, but can be obtained using natural-
abundance lead salts. We hope that 207Pb NMR spectroscopy
may now be useful to identify and characterize proteins
associated with lead toxicity directly from human samples if a
sufficiently concentrated sample can be obtained.
Experimental Section
Peptide synthesis and purification: All of the peptides were synthe-
sized on an Applied Biosystems 433A peptide synthesizer by using
standard Fmoc/tBu-based protection strategies on Rink Amide
MBHA resin (0.25 mmol scale) with HBTU/HOBt/DIEPA coupling
methods.[47] The peptides were then cleaved from the resin either
using a mixture of 95% trifluoroacetic acid (TFA), 2.5% ethanedi-
thiol, and 2.5% triisopropyl silane or a mixture of 90% TFA, 5%
thioanisole, 3% ethanedithiol, and 2% anisole. The cleaved peptide
solutions were filtered and then evaporated under a dry N2 flow to
give a glassy film. The white film was washed with ice-cold diethyl
ether (peroxide free) to obtain a crude peptide powder. The peptides
were dissolved in 10 % acetic acid, lyophilized, and subsequently
purified by reverse-phase HPLC (Waters 600 with Vydac protein and
peptide C-18 column; solvent A: 0.1% TFA in H2O; solvent B: 0.1%
TFA in acetonitrile/H2O (9:1); linear gradient 20–80% of solvent B
over 30 min; flow rate: 10 mLmin1). The identity and purity of the
purified peptides was confirmed by electrospray mass spectrometry
(Waters) in positive-ion mode and by analytical HPLC. The purity of
peptides was more than 95%. All of the peptides studied herein were
N-terminally acetylated and C-terminally amidated. A list of the
peptides synthesized with their sequences is given in Table 1.
Natural abundance 207Pb NMR spectroscopy: NMR samples (10–
12 mm) were prepared under a nitrogen atmosphere by dissolving of
pure and dried peptide (70–80 mg) in D2O/H2O (15%, 400–500 mL;
degassed). The peptide concentration was determined by Ellmans
test.[48] Calculated amounts of 250 mm Pb(NO3)2 (natural abundance)
stock solution was added to the peptide solution and the pH was
adjusted by the slow addition of a small aliquot of KOH/15% D2O
until the pH reached 7.35 0.05. All of the 207Pb NMR spectra were
recorded at a frequency of 104.435 MHz on a Varian 500 MHz NMR
spectrometer at room temperature (25 8C) using 608 pulses, a 20 ms
relaxation delay, and a 20 ms acquisition time. Initially, a large
spectral width of 300 KHz was used to find the position of the peak.
Once the peak position was found, the spectral window was reduced
to about 166 KHz. However, the chemical shift difference was not
observed when the spectral window was about 300 KHz (3000 ppm),
166 KHz (1500 ppm), or 50 KHz (500 ppm). A linear prediction was
performed to remove the noise, and the real FID was determined
before the data processing. After zero-filling, the data (128 K data
points) were processed with an exponential line broadening of 200–
250 Hz using the software MestRe-C.[49] The 207Pb NMR chemical
shifts are reported downfield from tetramethyllead (d = 0 ppm;
toluene) using 1.0m Pb(NO3)2 salt (natural) as an external standard
(d =2990 ppm, D2O, 25 8C; relative to PbMe4).
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